NIBIB in the News

Biomedical engineers at Duke University have demonstrated the most effective treatment for pancreatic cancer ever recorded in mouse models. While most mouse trials consider simply halting growth a success, the new treatment completely eliminated tumors in 80% of mice across several model types, including those considered the most difficult to treat. Source: Science Daily/Duke University

Researchers have developed a low-cost imaging system that can provide quantitative information about how deep within tissue a cancer cell resides. The system can help surgeons distinguish healthy tissue from tumors and could minimize health disparities in low-resource clinical centers. Source: Science Daily/Optica

NIBIB's Grace Peng provides an overview of the new NIH Bridge2AI program in an interview with Mimi Geerges. Source: Government Matters

NIBIB Intramural Research Program labs collaborate with other NIH researchers on tackle engineering challenges.

New computed tomography (CT) technology paired with artificial intelligence (AI)-based noise reduction offers superior detection of bone disease associated with multiple myeloma at lower radiation doses than conventional CT, according to a new study. Source: Science Daily/Radiological Society of North America

Using a suspended nanowire, a research team has created a tiny sensor that can simultaneously measure electrical and mechanical cellular responses in cardiac tissue, work promising for cardiac disease studies, drug testing and regenerative medicine. Source: Science Daily/University of Massachusetts Amherst

A team of researchers has developed a new class of biomaterial inks that mimic native characteristics of highly conductive human tissue, much like skin, which are essential for the ink to be used in 3D printing. Source: Science Daily/Texas A&M University

By combining optical measurements with ultrasound, researchers were able to study oxygen levels in the placenta, paving the way for a better understanding of this complex, crucial organ. Source: Science Daily/University of Pennsylvania

The Council on Strategic Risks hosted a webinar on June 8 titled RADx® Initiative & COVID-19 Solutions: Bioengineering at Unprecedented Speed and Scale. This NIH RADx Initiative was critical in the shift from solely laboratory-based testing to the public-private partnership that enabled the production and accessibility of point-of-care and over-the-counter COVID-19 tests. Source: Council on Strategic Risks

As more machine learning tools reach patients, developers are starting to get smart about the potential for bias to seep in. But a growing body of research aims to emphasize that even carefully trained models — ones built to ignore race — can breed inequity in care. Source: STAT